UAN CVR PARTNERS, LP
Agricultural Chemicals · NYSE · SEC CIK 1425292 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.3%
TTM net income YoY-16.4%
TTM EPS YoY-16.4%
Revenue 3-yr CAGR-4.3%
Net income 3-yr CAGR-25.5%
Margins
Gross margin26.5%
Operating margin20.6%
Net margin16.1%
FCF margin22.6%
EBITDA margin34.0%
Returns
ROE—
ROA10.2%
ROIC (approx.)—
Asset turnover0.63x
Leverage & solvency
Liabilities / assets—
Debt / equity—
Current ratio1.65x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.23x
Accruals ratio-12.5%
Payout ratio—
Capex / revenue13.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $146.15M | $202.19M | $180.05M | $131.06M | $163.55M | $168.56M | $142.87M | $139.56M |
| Cost of revenue | $137.69M | $108.97M | $112.59M | $125.29M | $103.03M | $113.92M | $100.43M | $106.39M |
| Gross profit | $8.47M | $93.22M | $67.45M | $5.78M | $60.52M | $54.63M | $42.44M | $33.16M |
| SG&A expense | $11.60M | $7.54M | $9.03M | $8.50M | $9.17M | $8.03M | $7.89M | $7.35M |
| Operating income | -$3.64M | $84.82M | $57.65M | -$2.88M | $50.64M | $46.32M | $34.59M | $25.73M |
| Pretax income | -$10.74M | $77.50M | $49.91M | -$10.29M | $43.07M | $38.77M | $27.09M | $18.40M |
| Income tax | $0 | $0 | $0 | -$23,000 | $0 | $0 | $0 | $102,000 |
| Net income | -$10.74M | $77.50M | $49.91M | -$10.27M | $43.07M | $38.77M | $27.09M | $18.30M |
| EBITDA | $19.61M | $107.04M | $77.61M | $20.12M | $70.59M | $67.18M | $52.63M | $49.76M |
| EPS (basic) | -1.02 | 7.33 | 4.72 | — | 4.08 | 3.67 | 2.56 | — |
| EPS (diluted) | -1.02 | 7.33 | 4.72 | — | 4.08 | 3.67 | 2.56 | — |
| Weighted avg. shares (diluted) | 10.57M | 10.57M | 10.57M | — | 10.57M | 10.57M | 10.57M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $158.19M | $137.46M | $128.09M | $69.24M | $156.18M | $114.40M | $121.78M | $90.86M |
| Receivables | $53.78M | $81.72M | $52.84M | $58.96M | $47.81M | $50.49M | $41.64M | $65.22M |
| Inventory | $84.79M | $94.02M | $88.31M | $82.68M | $81.85M | $73.86M | $80.39M | $75.58M |
| Current assets | $298.73M | $314.99M | $271.20M | $213.87M | $288.55M | $242.20M | $247.11M | $233.54M |
| PP&E, net | $709.98M | $698.59M | $704.37M | $711.82M | $705.32M | $713.06M | $722.93M | $735.59M |
| Total assets | $1.06B | $1.06B | $1.02B | $969.46M | $1.04B | $998.00M | $1.01B | $1.02B |
| Current liabilities | $181.47M | $104.62M | $98.57M | $96.77M | $107.73M | $70.27M | $98.94M | $111.35M |
| Short-term debt | $847,000 | $824,000 | $801,000 | $778,000 | $757,000 | $738,000 | $718,000 | $877,000 |
| Long-term debt | $568.89M | $568.96M | $569.01M | $569.07M | $569.12M | $569.23M | $569.27M | $567.97M |
| Total debt | $569.74M | $569.78M | $569.82M | $569.85M | $569.88M | $569.97M | $569.99M | $568.85M |
| Shareholders' equity | — | — | — | — | — | — | — | — |
| Net debt | $411.55M | $432.32M | $441.73M | $500.60M | $413.69M | $455.57M | $448.22M | $477.99M |
| Cash flow statement | ||||||||
| Operating cash flow | $116.71M | $65.90M | $75.78M | -$21.60M | $91.74M | $24.10M | $55.39M | $12.79M |
| Capital expenditure | $32.47M | $15.00M | $17.05M | $23.57M | $11.62M | $5.75M | $9.87M | $18.35M |
| Free cash flow | $84.25M | $50.91M | $58.73M | -$45.17M | $80.13M | $18.36M | $45.52M | -$5.55M |
| Investing cash flow | -$31.52M | -$14.06M | -$12.84M | -$22.67M | -$10.73M | -$4.88M | -$5.81M | -$17.54M |
| Financing cash flow | -$64.46M | -$42.47M | -$4.10M | -$42.67M | -$39.23M | -$26.59M | -$18.67M | -$14.94M |
| Depreciation & amortization | $23.25M | $22.22M | $19.96M | $23.01M | $19.96M | $20.86M | $18.04M | $24.03M |
| Stock-based compensation | $4.47M | $362,000 | $2.99M | $2.23M | $3.27M | $2.83M | $1.47M | $1.48M |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.